These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12021883

  • 1. Growth dynamics of meningiomas in patients with multiple sclerosis treated with interferon: report of two cases.
    Batay F, Al-Mefty O.
    Acta Neurochir (Wien); 2002 Apr; 144(4):365-8. PubMed ID: 12021883
    [Abstract] [Full Text] [Related]

  • 2. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L, Neves M, Cardoso E, Melo A.
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [Abstract] [Full Text] [Related]

  • 3. Meningioma growth and interferon beta-1b treated multiple sclerosis: coincidence or relationship?
    Drevelegas A, Xinou E, Karacostas D, Parissis D, Karkavelas G, Milonas I.
    Neuroradiology; 2005 Jul; 47(7):516-9. PubMed ID: 15981002
    [Abstract] [Full Text] [Related]

  • 4. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S, Vardi J, Finkelstein Y, Pollak L.
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?
    Hügle T, Gratzl S, Daikeler T, Frey D, Tyndall A, Walker UA.
    Ann Rheum Dis; 2009 Jan; 68(1):47-50. PubMed ID: 18203763
    [Abstract] [Full Text] [Related]

  • 9. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y, Kawachi Y, Furuta J, Otsuka F.
    Eur J Dermatol; 2008 Jan; 18(5):579-82. PubMed ID: 18693165
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multiple meningiomas of different pathological features: case report.
    Koh YC, Yoo H, Whang GC, Kwon OK, Park HI.
    J Clin Neurosci; 2001 May; 8 Suppl 1():40-3. PubMed ID: 11386824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Betaseron: a breakthrough treatment for multiple sclerosis.
    Morrison W, Nelson J.
    Can Nurse; 1996 Oct; 92(9):38-41. PubMed ID: 9118060
    [Abstract] [Full Text] [Related]

  • 18. Concurrence of multiple sclerosis and intracranial glioma. Report of a case and review of the literature.
    Shuangshoti S, Hjardermaal GM, Ahmad Y, Arden JL, Herman MM.
    Clin Neuropathol; 2003 Oct; 22(6):304-8. PubMed ID: 14672509
    [Abstract] [Full Text] [Related]

  • 19. Interferon causes no myasthenia in a seropositive patient with multiple sclerosis.
    Shimizu H, Kataoka H, Kawahara M, Hirano M, Furiya Y, Ueno S.
    Clin Neurol Neurosurg; 2007 Apr; 109(3):277-8. PubMed ID: 17118531
    [Abstract] [Full Text] [Related]

  • 20. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ, Cowan BJ, Hashimoto SA.
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.